BioSpace News Archive

Nektar Therapeutics will announce its financial results for the first quarter on Thursday, May 10, 2018

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the treatment of the first patient in a Phase 1, open-label, proof-of-concept clinical trial

In a new study just published in the journal Nature, researchers have discovered patterns of abnormal brain activity that produce motor deficits in Parkinson’s disease (PD).

Eli Lilly Canada Inc. (Lilly) is proud to announce that Humalog® [insulin lispro injection 100 units/mL] Junior KwikPen® is approved by Health Canada and now available to Canadians with diabetes.

Colon cancer cut short the life of legendary football coach Vince Lombardi at the age of 57 and, nearly 50 years later, remains the number two cancer killer in the United States.

- ADVISOR™ HD GRID MAPPING CATHETER, SENSOR ENABLED™ FACILITATES IMPROVED DATA COLLECTION, SUPPORTING OPTIMAL TREATMENT FOR PATIENTS WITH COMPLEX CARDIAC ARRHYTHMIAS - FIRST-OF-ITS-KIND GRID CONFIGURATION IS DESIGNED TO CAPTURE DATA IN MULTIPLE DIRECTIONS TO CREATE HIGH-DENSITY MAPS OF THE HEART - NOVEL MAPPING CATHETER COMPLEMENTS THE ENSITE PRECISION™ CARDIAC MAPPING SYSTEM AND EXPANDS ABBOTT’S ADVANCED CARDIAC MAPPING PORTFOLIO

Change Healthcare unveiled a new version of Acuity Revenue Cycle Analytics™.

JDRF announces the awarding of a research grant to International Diabetes Center (IDC) in Minneapolis.

According to Grand View Research, Inc. the global medical cannabis market is expected to reach a value of USD 55.8 billion by 2025.

TechCare Corp. announced it will launch its Novokid Lice Treatment Products Line in Super Pharm, Israel’s largest and leading drugstore chain.